Georgia Cancer Center — Augusta, Georgia

Public research footprint of Georgia Cancer Center, compiled from the ClinicalTrials.gov public registry.

183

Registered studies

Active

Recruiting now

107

Completed

Stopped or withdrawn

Most-studied conditions

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung… · Ovarian Cancer · Endometrial Cancer · Hormone Receptor-positive/Her2 Negative Breast Cancer

Recently updated registry entries

NCT06459180 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… (Active Not Recruiting)
NCT06824467 — A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870)… (Recruiting)
NCT06425991 — A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Georgia Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.